Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.
about
Nonpharmacologic management of behavioral symptoms in dementiaNonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic ReviewManagement of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panelAssessment and management of behavioral and psychological symptoms of dementiaThe long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's diseaseTreatment characteristics of patients with dementia: comparing two different psychiatric inpatient settings.Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.Packages of care for dementia in low- and middle-income countries.Psychiatric Aspects of Dementia.Psychotropic drug use and mortality in old people with dementia: investigating sex differences.Evaluation of exercise on individuals with dementia and their carers: a randomised controlled trial.Patterns and trends in antipsychotic prescribing for Parkinson disease psychosisQuantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Profile and variables related to antipsychotic consumption according to dementia subtypes.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings.Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Risk of mortality among individual antipsychotics in patients with dementiaOlanzapine induced Q-Tc shortening.Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based studyBetween Scylla and Charybdis: antipsychotic and other psychotropic medications in older nursing home residentsPredictors of suicide in patients with dementia.Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.Use of anti-dementia drugs in home care and residential care and associations with neuropsychiatric symptoms: a cross-sectional studySymptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trialAtypical antipsychotic use in patients with dementia: managing safety concerns.Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot studyAntidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.Senior adult oncology.Beyond the Black Box: What is The Role for Antipsychotics in Dementia?Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort studyPost-graduate CMEVascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
P2860
Q24598981-274BCFFB-B02D-4A08-B341-FC55B6D11BBDQ26773524-FD2BF861-D148-42B1-8FC6-EF6520EA3F17Q26864923-ABE84DBD-A0E3-463D-B728-D83494FE4D94Q28088782-491DA5BE-9D5F-4161-B5AE-BF7B1B86C0BDQ30413790-431FC806-A8BF-4807-8DBA-ABFF5749E843Q30544639-F7AF6B8D-1138-49A1-AFF6-47BF5D03887CQ31113747-9133F4D6-75C5-4014-9130-F7D0E4AACC06Q33514859-4FC17D8C-D9EC-4986-9731-BADC9DC5F088Q33562417-60161D0A-5DEE-4E5E-A132-20B74046F600Q33729950-16AEF33B-1E91-463B-A1F3-4F6100F27E04Q33898470-DD0569D0-3035-4EC0-B53B-82FC7BC2F6AEQ33957582-59378274-7B74-41F9-9B32-42F8AD9F5683Q34070862-B1358EA7-CD26-45E7-A420-2E1A425278F0Q34158495-8C03C7BA-ECC9-4575-9294-0AF96F913280Q34298335-B95E287E-4699-417F-BAB4-5FD2BD80B8F8Q34402997-026972FE-40B4-45E7-9CA5-41B904DF535AQ34438066-4B8B1EBF-C26E-4A02-BDDB-93A08E3DC08FQ34452896-DCE799AC-C7C5-41E2-ADD3-75F2C14B0DFCQ34571959-428CDAFC-019B-4849-A8E6-C04CBF16E274Q34634590-9AE37B39-3779-47D4-BA10-0BF8F72E1590Q34642834-E44E04BB-24C9-4BC1-92B3-415C53B36784Q34734083-3CB9102F-DF1C-4AEB-A312-952911213175Q34828456-350181E2-3D27-499A-8046-AF97A1D11D7FQ35534414-0D88CEE0-89CC-4F34-899A-ADAE98533C31Q35619443-17346055-F9D7-4878-B278-16C1F099620AQ35630897-E8AE5227-354D-4754-9E0B-7F68F74DDC34Q35744523-22D79A14-97FD-4EA2-8C12-569B6B288001Q35765716-2013B041-5EB9-45CC-A940-64B86D89BFC3Q35975139-9DB94804-D657-4A34-84FC-E683440A8CEEQ36345261-322A0A7E-B289-44B4-B79A-812F414206FBQ36450333-C38FA43C-DC98-4536-9261-01E5D5F78B47Q36498425-DEF6C979-5827-4A8F-9094-4A556DC73C54Q36706808-17CDABCE-A1B9-4032-80F2-BCEE5DA629D9Q36851424-BCABF6DE-E343-4063-A790-2AC4D19F1266Q37094302-7D72DC76-029D-43C3-804E-50DCACB03F18Q37156481-DA6EE4A1-036F-4BA4-81F1-A2654A6306DCQ37177773-776DE544-39F8-41F5-9851-8856C1E80B26Q37334124-2F8E33BA-9BA6-41F2-A8CD-5830129A072DQ37445941-510328F9-39CD-4119-BCD4-0E1B6C58601EQ37505818-1C028743-B28F-4C63-9A49-7B10A8DED6F3
P2860
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Mortality risk in patients wit ...... other psychiatric medications.
@en
Mortality risk in patients wit ...... other psychiatric medications.
@nl
type
label
Mortality risk in patients wit ...... other psychiatric medications.
@en
Mortality risk in patients wit ...... other psychiatric medications.
@nl
prefLabel
Mortality risk in patients wit ...... other psychiatric medications.
@en
Mortality risk in patients wit ...... other psychiatric medications.
@nl
P2093
P1476
Mortality risk in patients wit ...... other psychiatric medications.
@en
P2093
Dara Ganoczy
Francesca Cunningham
Frederic C Blow
H Myra Kim
Helen C Kales
John F McCarthy
P304
1568-76; quiz 1623
P356
10.1176/APPI.AJP.2007.06101710
P407
P577
2007-10-01T00:00:00Z